ROK Stars PLC and Alpha Prospects PLC in Share Swap Agreement

Ticker Symbol: RKS
WKN: A1H7NB

Thursday 6th June 2013

ROK Stars PLC, the consumer products development company founded by US Billionaire John Paul DeJoria and UK entrepreneur Jonathan Kendrick, has announced a ‘share swap’ with Alpha Prospects PLC.

ROK Stars PLC is listed on the Stuttgart Stock Exchange whilst Alpha Prospects PLC is listed on the ISDX Growth Market, a market for unlisted securities with a regulatory framework dedicated to the needs of smaller companies and is part of the ICAP Securities & Derivatives Exchange.

The parties have agreed that Alpha will subscribe for 292,583 new ROK Stars Ordinary Shares and the subscription price to be paid by Alpha will be the sum of £450,000 to be satisfied by the issue of 18,000,000 new Alpha Ordinary Shares in the capital of Alpha at a price of 2.5 pence per share.

Commenting, Jonathan Kendrick, Chairman of ROK Stars said “We are delighted to have reached this share swap agreement with Alpha Prospects as we believe this will result in significant investment into the development of our expanding portfolio of game-changing consumer products.”

ROK Stars is listed on the Stuttgart Stock Exchange and has an expanding portfolio of ‘game-changing’ products which includes OVAL Vodka, ROK Natural Energy, ROK Water and PURE ROK – with several more products currently under review and evaluation.

“All our ROK Stars products have the potential to achieve what Patron has in the tequila market and what Paul Mitchell has achieved in the hair care market; to become billion dollar brands.” Added John Paul DeJoria.

Safe Harbor Statement:

The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward- looking statements, including, but not limited to, certain delays beyond the company’s control with respect to market acceptance of new technologies or products, delays in testing and evaluation of products, and other risks detailed from time to time.

Related Posts